For Members
NEWS ROOM
Media Materials
- Press Releases
- Journal Tipsheets
- Meetings Information
- ASM Advisories
- RSS Feed 'What's New in ASM Newsroom'
Welcome to the ASM Newsroom, a resource for journalists seeking information relating to the microbiological sciences. Members of the media and the general public can access current and archived press releases from the Society as well as tipsheets highlighting the latest research published in our journals or presented at our meetings.
News Media Contacts:
Jim Sliwa
Manager, Media Relations
jsliwa@asmusa.orgGarth Hogan
Media Relations Coordinator
ghogan@asmusa.org
Click here to subscribe to our listserv and receive press releases and other updates by email.
What's New in News Room?
Vacuum Dust: A Previously Unknown Disease Vector
WASHINGTON, DC – September 30, 2013 -- The aerosolized dust created by vacuums contain bacteria and mold that “could lead to adverse effects in allergic people, infants, and people with compromised immunity,” according to researchers at the University of Queensland and Laval University. Their findings are published in the October issue...
09-30-2013
Scientists Engineer Strain of MERS Coronavirus for Use in a Vaccine
WASHINGTON, DC – September 10, 2013 -- Scientists have developed a strain of the Middle East respiratory syndrome coronavirus (MERS-CoV) that could be used as a vaccine against the disease, according to a study to be published in mBio®, the online open-access journal of the American Society for Microbiology.
09-10-2013
Programmed Cell Death Activates Latent Herpesviruses
WASHINGTON, DC – September 5, 2013 – Researchers have found that apoptosis, a natural process of programmed cell death, can reactivate latent herpesviruses in the dying cell. The results of their research, which could have broad clinical significance since many cancer chemotherapies cause apoptosis, was published ahead of print in the Journal...
09-05-2013
Pain-Free Microneedle Influenza Vaccine is Effective, Long-lasting
WASHINGTON, DC – September 4, 2013 -- Scientists have developed an influenza vaccine delivered via microneedle patch that provided 100 percent protection against a lethal influenza virus in mice more than one year after vaccination. They report their findings in the September 2013 issue of the journal Clinical and Vaccine Immunology.
09-04-2013
ASM Announces Change of Leadership
WASHINGTON, DC – September 3, 2013 – The American Society for Microbiology (ASM) announces that as of September 1, 2013, the Society’s current president, Jo Handelsman of Yale University, has stepped down from her position. In accordance with the organization’s bylaws, the governing body of the ASM has appointed its immediate...
09-03-2013
Commentary Explores FDA Reboot: What Brought it on, What’s Being Done
WASHINGTON, DC – August 29, 2013 -- The increasing public health threat posed by continuing rise of antibiotic resistance combined with inadequate development of new antibiotics is largely the fault of the U.S. Food and Drug Administration (FDA) according to a commentary published ahead of print in the journal Antimicrobial Agents and...
08-29-2013
Protein Predicts Breast Cancer Prognosis
WASHINGTON, DC – August 29, 2013 -- Researchers have identified a protein that they believe may help predict breast cancer prognosis, potentially relieving thousands of women at low risk from having to undergo painful, oft-debilitating therapies, while insuring the most successful treatments for those at high risk. The research was published...
08-29-2013
Report Proposes Microbiology’s Grand Challenge to Help Feed the World
WASHINGTON, DC – August 27, 2013 -- A greater focus on the role of microbiology in agriculture combined with new technologies can help mitigate potential food shortages associated with world population increases according to a new report from the American Academy of Microbiology.
08-27-2013
Gene Makes Some HIV-Infected Patients More at Risk for Fungal Disease
WASHINGTON, DC – August 27, 2013 -- HIV-infected people who carry a gene for a specific protein face a 20-fold greater risk of contracting cryptococcal disease, according to a study published in mBio®, the online open-access journal of the American Society for Microbiology.
08-27-2013
Target Two Forms of Iron to Control Cystic Fibrosis Lung Infection
WASHINGTON, DC – August 20, 2013 -- The bacterium Pseudomonas aeruginosa needs iron to establish and maintain a biofilm in the lungs of cystic fibrosis patients, and therapies have been proposed to deprive the bacteria of this necessary element. However, these techniques may not work, according to a new study published in mBio®, the...
08-20-2013